Webinar: Prospects for COVID-19 Medicines (Revisited)
COVID-19 has been a major disruptor to global healthcare systems and has had significant impacts on global economies. This online presentation will consider the progress to date, prospects and timelines for vaccines and other medicines to prevent and/or treat COVID-19. It will argue that advances in antivirals, antibody therapies, immunomodulators and vaccines will all be needed to bring COVID-19 under control.
The recording of this event is now available on:
This presentation follows on from the well-received “Prospects for COVID-19 Medicines” presentation given on 1 May 2020.
You can re-watch the “Prospects for COVID-19 Medicines” webinar via:
actuview: https://www.actuview.com/prospects-for-covid-19-medicines_cf53ec3ca.htm…;
or YouTube: https://www.youtube.com/watch?v=v7ybsCINDCg&feature=youtu.be
This presentation should be of interest to all actuaries, healthcare professionals and policy makers.
To register for this event, please proceed with 'Make a reservation' below and we will send you details of your ZOOM invite shortly.
Over the past decade, Ivor has invested in over 500 listed biotech companies. Over one third of these biotechs developed medicines for infectious diseases. As a result, Ivor has significant practical experience in assessing the prospects and timelines for potential new medicines. Ivor also had a prior career in the life assurance & health insurance industries that lasted just under a combined quarter of a century. Ivor is a member of the Society’s Healthcare Committee.